Czechia, March 30 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Fakultni nemocnice u sv. Anny v Brne for Pharmaceutical products L04AG05 VEDOLIZUMAB. The value of the contract is worth 2780450752 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....